查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1520622

合成生物學的全球市場的評估:各工具，各技術，各用途，各終端用戶，各地區，機會，預測，2017年～2031年

Synthetic Biology Market Assessment, By Tools, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

2024-2031年預測期間，全球合成生物學市場規模將以20.29%的複合年增長率擴大，從2023年的152.1億美元增長到2031年的666.8億美元。

合成生物學的科學領域涉及工程概念的生物學應用。生物材料、生物技術、系統生物學、化學和生物工程、電氣和電腦工程以及演化生物學只是屬於這個跨學科領域的一些專業。合成生物學涉及為實際應用重新設計微生物。擴展天然存在的蛋白質的庫和開發新的過程，以及識別和編目標準化的遺傳構件以構建創新的生物系統，是合成生物學的重要組成部分，這是主要目的之一。增加對尖端程序和技術的投資、增加對合成基因和細胞的需求以及擴大合成生物學的應用領域是推動市場擴張的關鍵因素。合成生物學在醫療保健、農業和能源等廣泛領域有著廣泛的應用，為解決難題和推動市場擴張開闢了新途徑。

不斷增加的研發成本也支持了合成??生物學領域新方法和程序的創建，促進了市場的創造力和競爭。此外，對合成基因和細胞不斷增長的需求正在擴大市場，凸顯了這些生物成分在各種生物技術應用中的重要性。這些相互關聯的因素共同決定了市場的發展軌跡，使企業有可能從合成生物學服務和產品不斷增長的需求中受益，同時推動科學和工業進步。

本報告提供全球合成生物學市場相關調查，提供市場概要，以及各工具，各技術，各用途，各終端用戶，各地區趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 調查手法

第2章 計劃的範圍和定義

第3章 摘要整理

第4章 全球合成生物學市場預測，2017年～2031年

  • 市場規模與預測
  • 各工具
  • 各技術
  • 各用途
  • 各終端用戶
  • 各地區
  • 各企業市場佔有率(%)、2023年

第5章 全球合成生物學市場預測，各地區，2017年～2031年

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第6章 市場製圖，2023年

第7章 宏觀環境和產業結構

  • 需求供給分析
  • 進出口分析
  • 價值鏈分析
  • PESTEL分析
  • 波特的五力分析

第8章 市場動態

第9章 法規結構和革新

第10章 主要加入企業的形勢

第11章 價格分析

第12章 案例研究

第13章 主要加入企業預測

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Novozymes AS
  • Eurofins Scientific
  • Amyris Inc.
  • Codexis, Inc.
  • GenScript Biotech Corporation
  • Viridos Inc. (Synthetic Genomics Inc.)
  • Twist Bioscience Corporation
  • Ginkgo Bioworks, Inc.

第14章 策略性建議

第15章 諮詢方式和免責聲明

Product Code: MX11644

Global synthetic biology market is projected to witness a CAGR of 20.29% during the forecast period 2024-2031, growing from USD 15.21 billion in 2023 to USD 66.68 billion in 2031.

The scientific field of synthetic biology is related to the biological application of engineering concepts. Biomaterials, biotechnology, systems biology, chemical and biological engineering, electrical and computer engineering, and evolutionary biology are just a few of the specialisations that are a part of this interdisciplinary field. In synthetic biology, microorganisms are redesigned for practical uses. Expanding the repertoire of naturally occurring proteins for novel processes and recognizing and cataloging standardized genetic components for the construction of innovative biological systems are among the main objectives of synthetic biology. Increased investments in cutting-edge procedures and techniques, the growing need for synthetic genes and cells, and the expanding applications of synthetic biology are the main drivers of market expansion. Synthetic biology has a wide range of applications in sectors including healthcare, agriculture, and energy that open new avenues for solving difficult problems and propelling market expansion.

In addition, rising R&D expenditures support the creation of novel methods and procedures in the field of synthetic biology, which promotes creativity and competitiveness in the marketplace. Additionally, the market is expanding due to the rising demand for synthetic genes and cells, which highlights the significance of these biological building blocks in a variety of biotechnological applications. These interconnected factors work together to define the market's trajectory, providing businesses with the possibility to profit from the rising demand for synthetic biology services and products while advancing scientific and industrial advancements. For instance, in May 2023, a diverse group of key opinion leaders (KOLs) and their strategic partner called Allozymes helped GenScript Biotech Corporation, which is the sponsor of the SynBioBeta Conference in Oakland, California, present the newest tools and approaches in synthetic biology.

Advancements in Molecular Biology Led to Market Expansion

Advancements in molecular biology have significantly propelled the growth of the synthetic biology market, a field dedicated to redesigning organisms for useful purposes by engineering them to have new abilities. Molecular biology techniques, such as Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR-Cas9) gene editing, next-generation sequencing, and advanced bioinformatics tools, have streamlined the process of DNA manipulation and analysis, making genetic engineering more precise, efficient, and cost-effective. CRISPR-Cas9, for instance, allows for targeted and highly specific genetic modifications, enabling scientists to edit genes with unprecedented accuracy. This precision is crucial for developing synthetic organisms with desired traits, such as microbes capable of producing biofuels, pharmaceuticals, or other valuable chemicals. Next-generation sequencing technologies provide comprehensive genomic data, facilitating the design of synthetic pathways and circuits by identifying and characterizing genetic components. Furthermore, advancements in bioinformatics have enabled the integration of vast amounts of biological data, aiding in the modeling and simulation of synthetic biological systems. This integration helps predict the behavior of engineered organisms, thus reducing trial-and-error experimentation and accelerating development timelines.

The ability to design and construct synthetic organisms more efficiently has opened new commercial avenues in various sectors, including healthcare, agriculture, and environmental management. For example, engineered microbes are used to produce insulin, biodegradable plastics, and crop-enhancing biofertilizers. These innovations address critical global challenges such as sustainable production and disease management, thereby driving market demand. In summary, the synergy between molecular biology and synthetic biology is creating a robust foundation for innovation, expanding the capabilities and applications of synthetic biology, and consequently driving market growth. For instance, the goal of the multi-stage collaboration between Octarine Bio, a synthetic biology company that develops new sustainable bio-based ingredients, and Ginkgo Bioworks, Inc. is to focus on compounds in the tryptophan pathway and engineer a strain that can produce violacein and its derivatives, a naturally occurring bis-indole pigment with potent bioactive properties like anti-microbial, antioxidant, and UV protection. This partnership was announced in May 2023.

Rising Demand for Precision Medicine Promotes Market Growth

The rising demand for precision medicine is significantly driving the expansion of the synthetic biology market. Precision medicine, which tailors medical treatment to the individual characteristics of each patient, relies heavily on the ability to understand and manipulate genetic information. Synthetic biology plays a crucial role in enabling these personalized medical approaches with its capacity to engineer biological systems. Firstly, synthetic biology facilitates the development of custom therapeutics, such as gene therapies and personalized drugs. By designing and constructing new genetic sequences, scientists can create treatments that specifically target the genetic mutations underlying a patient's disease. This precision in targeting improves the efficacy and safety of treatments, making synthetic biology indispensable in precision medicine. Moreover, synthetic biology contributes to the advancement of diagnostic tools. Engineered biosensors and diagnostic platforms can detect biomarkers at unprecedented levels of sensitivity and specificity. These innovations enable early detection and accurate monitoring of diseases, which are critical components of precision medicine strategies.

The growing adoption of precision medicine also spurs investment in synthetic biology research and development. Biotech companies and research institutions are increasingly focusing on synthetic biology to meet the rising demand for personalized medical solutions. This influx of funding accelerates the innovation cycle, leading to more advanced and commercially viable synthetic biology applications. In addition, regulatory support for precision medicine, along with public and private sector collaborations, further propels the synthetic biology market. Governments and organizations recognize the potential of precision medicine to transform healthcare, thus driving policies and partnerships that favor the development and integration of synthetic biology technologies. Overall, the synergy between precision medicine and synthetic biology not only enhances patient outcomes but also significantly expands the synthetic biology market, fostering a new era of personalized healthcare solutions.

For example, Bit.bio, a startup that codes human cells for cutting-edge treatments, and Ginkgo Bioworks, Inc., a business creating the industry's best platform for cell programming and biosecurity, announced Bit.bio as the Ginkgo Technology Network's first partner on February 28, 2024. The Network is an innovative group of state-of-the-art technology partners committed to working with Ginkgo Bioworks, Inc. to provide new, integrated capabilities that make customer R&D projects successful.

Increasing Dominance of Healthcare Segment Leading to Market Growth

The healthcare sector is now opting for a variety of therapeutic treatments utilizing modified phages, artificial cells, and live bacteria due to the rapid growth of synthetic biology. It has made it possible for life technologies to quickly develop and produce antigens and their variations with high expression, capacity, and speed. Applications for synthetic biology range from manufacturing and diagnostic tests to the development of drugs and vaccines. Governmental and non-governmental activities are anticipated to have a favorable impact on this market area. For example, in July 2022, SynBioVen, Limited awarded a grant of USD 6.6 million (GBP 5.5 million) to SynbiCITE, the National Centre for the Industrial Translation of Synthetic Biology in the United Kingdom. With this funding, the imperial-hosted center would be able to further assist small and medium-sized businesses and startups in the field of synthetic biology, bolster the United Kingdom's developing economy, and unleash the potential benefits of synthetic biology for society as a whole. In a ground-breaking development that eliminates the need for eggs or sperm, researchers demonstrated the generation of synthetic human embryos using stem cells in June 2023 at the annual meeting of the International Society for Stem Cell Research. These model embryos, which mimic the earliest stages of human development, are thought to offer a vital window into the effects of genetic diseases and the biological causes of recurrent miscarriages, according to scientists.

Thus, advancements in synthetic biology-related healthcare are anticipated to accelerate market expansion. Therefore, due to the above-mentioned factors, including ongoing research and advances in synthetic biology for healthcare areas, the healthcare segment is anticipated to experience significant growth during the projection period.

North America to Dominate the Synthetic Biology Market

The market for synthetic biology is predicted to grow significantly in North America because of the region's growing demand for bio-based goods, growing investments in synthetic biology startups, and rising financing for synthetic biology research and development. The region's synthetic biology market is growing because of the United States' significant contributions to research in drug discovery, genomics, and proteomics structure prediction, in general. Governmental bodies like the National Institutes of Health (NIH) and private organizations like the Gates and Melinda Foundation have funded several universities and research institutes to develop bioinformatics, DNA sequencing, biological components, and integrated systems devices that have a wide range of applications in healthcare and other fields. The Canadian government invested more than USD 4.13 million (CAD 5.6 million) in October 2022 to help early-stage genomics companies launch new products. This would facilitate the application of artificial intelligence (AI), automation, miniaturization, and computers to molecular biosciences related to synthetic biology or genetic engineering. Similarly, the products developed by the Twist Bioscience Corporation's manufacturing plant, called the Factory of the Future in Oregon, U.S., were shipped in January 2023. Twist Bioscience Corporation helps its customers thrive by offering high-quality synthetic DNA on its silicon platform. Moreover, growing support from public and private organizations, as well as R&D expenditures for medication research and improvement, are significant growth drivers anticipated to propel the market throughout the period.

Future Market Scenario (2024-2031F)

The main factors contributing to the anticipated growth of the synthetic biology market are the increasing demand for personalized medication and the need to develop better drugs. Not only this, but the declining cost of DNA sequencing and synthesizing is a factor that will always propel the market growth. Given that technology is advancing, cutting-edge technology in the area is expected. Players in this market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. Government policies and policies made by welfare bodies are also greatly fueling the market expansion. For instance, the Rice Synthetic Biology Institute was established by Rice University of the United States in January 2024 with the goal of fostering cooperative research in synthetic biology and its application to the development of technologies that advance society.

Key Players Landscape and Outlook

Several companies such as Thermo Fisher Scientific, Inc., Merck KGaA, Novozymes AS, Eurofins Scientific, Amyris Inc., Codexis, Inc., GenScript Biotech Corporation, Viridos Inc. (Synthetic Genomics Inc.), Twist Bioscience Corporation, Ginkgo Bioworks, Inc., etc., are expanding business by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launches of newly developed biologics to help researchers and to strengthen their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments and partnerships are a few ways through which they are trying to achieve the same.

For instance, to improve results for patients with chronic illnesses, AMC Health, a healthcare organization, established a service relationship with the University of Mississippi Medical Center in March 2023. The goal of this collaboration is to expand the market for synthetic biology and open up new avenues for patient care systems that go beyond conventional hospital settings.

Similarly, expanding their current biomanufacturing partnership, Sumitomo Chemical Co., Ltd. and Ginkgo Bioworks, Inc. announced a new project in July 2023 to use synthetic biology to create functional chemicals. The two have been using Ginkgo Bioworks Inc.'s platform since 2021 to create a variety of goods in the fields of personal care, cosmetics, agriculture, and pharmaceuticals. This latest initiative is their third collaborative effort and is positioned to enable large-scale fermentation-based manufacture of useful compounds.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Synthetic Biology Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. By Tools
    • 4.2.1. Oligonucleotides
    • 4.2.2. Enzymes
    • 4.2.3. Cloning Kits
    • 4.2.4. Synthetic Cells
    • 4.2.5. Chassis Organisms
    • 4.2.6. Xeno Nuclei Acid
  • 4.3. By Technology
    • 4.3.1. Gene Synthesis
    • 4.3.2. PCR Technology
    • 4.3.3. Bioprocessing Technology
    • 4.3.4. NGS Technology
    • 4.3.5. Bioinformatics
    • 4.3.6. Nanotechnology
    • 4.3.7. Others
  • 4.4. By Application
    • 4.4.1. Healthcare
    • 4.4.2. Non-Healthcare
  • 4.5. By End-user
    • 4.5.1. Pharmaceutical and Biopharmaceutical Companies
    • 4.5.2. Academic and Research Institutes
    • 4.5.3. Others
  • 4.6. By Region
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia-Pacific
    • 4.6.4. South America
    • 4.6.5. Middle East and Africa
  • 4.7. By Company Market Share (%), 2023

5. Global Synthetic Biology Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
    • 5.1.2. By Tools
      • 5.1.2.1. Oligonucleotides
      • 5.1.2.2. Enzymes
      • 5.1.2.3. Cloning Kits
      • 5.1.2.4. Synthetic Cells
      • 5.1.2.5. Chassis Organisms
      • 5.1.2.6. Xeno Nuclei Acid
    • 5.1.3. By Technology
      • 5.1.3.1. Gene Synthesis
      • 5.1.3.2. PCR Technology
      • 5.1.3.3. Bioprocessing Technology
      • 5.1.3.4. NGS Technology
      • 5.1.3.5. Bioinformatics
      • 5.1.3.6. Nanotechnology
      • 5.1.3.7. Others
    • 5.1.4. By Application
      • 5.1.4.1. Healthcare
      • 5.1.4.2. Non-Healthcare
    • 5.1.5. By End-user
      • 5.1.5.1. Pharmaceutical and Biopharmaceutical Companies
      • 5.1.5.2. Academic and Research Institutes
      • 5.1.5.3. Others
    • 5.1.6. United States*
      • 5.1.6.1. Market Size & Forecast
        • 5.1.6.1.1. By Value
      • 5.1.6.2. By Tools
        • 5.1.6.2.1. Oligonucleotides
        • 5.1.6.2.2. Enzymes
        • 5.1.6.2.3. Cloning Kits
        • 5.1.6.2.4. Synthetic Cells
        • 5.1.6.2.5. Chassis Organisms
        • 5.1.6.2.6. Xeno Nuclei Acid
      • 5.1.6.3. By Technology
        • 5.1.6.3.1. Gene Synthesis
        • 5.1.6.3.2. PCR Technology
        • 5.1.6.3.3. Bioprocessing Technology
        • 5.1.6.3.4. NGS Technology
        • 5.1.6.3.5. Bioinformatics
        • 5.1.6.3.6. Nanotechnology
        • 5.1.6.3.7. Others
      • 5.1.6.4. By Application
        • 5.1.6.4.1. Healthcare
        • 5.1.6.4.2. Non-Healthcare
      • 5.1.6.5. By End-user
        • 5.1.6.5.1. Pharmaceutical and Biopharmaceutical Companies
        • 5.1.6.5.2. Academic and Research Institutes
        • 5.1.6.5.3. Others
    • 5.1.7. Canada
    • 5.1.8. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East and Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Tools
  • 6.2. By Technology
  • 6.3. By Application
  • 6.4. By End-user
  • 6.5. By Region

7. Macro Environment and Industry Structure

  • 7.1. Demand Supply Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat From New Entrants
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Thermo Fisher Scientific, Inc.
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products and Services
    • 13.1.4. Financials (As Reported)
    • 13.1.5. Key Market Focus and Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Merck KGaA
  • 13.3. Novozymes AS
  • 13.4. Eurofins Scientific
  • 13.5. Amyris Inc.
  • 13.6. Codexis, Inc.
  • 13.7. GenScript Biotech Corporation
  • 13.8. Viridos Inc. (Synthetic Genomics Inc.)
  • 13.9. Twist Bioscience Corporation
  • 13.10. Ginkgo Bioworks, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 3. Global Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 4. Global Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 5. Global Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 6. Global Synthetic Biology Market Share (%), By Region, 2017-2031F
  • Figure 7. North America Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 8. North America Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 9. North America Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 10. North America Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 11. North America Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 12. North America Synthetic Biology Market Share (%), By Country, 2017-2031F
  • Figure 13. United States Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 14. United States Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 15. United States Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 16. United States Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 17. United States Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 18. Canada Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 19. Canada Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 20. Canada Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 21. Canada Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 22. Canada Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 23. Mexico Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 24. Mexico Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 25. Mexico Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 26. Mexico Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 27. Mexico Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 28. Europe Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 29. Europe Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 30. Europe Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 31. Europe Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 32. Europe Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Synthetic Biology Market Share (%), By Country, 2017-2031F
  • Figure 34. Germany Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 35. Germany Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 36. Germany Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 37. Germany Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 38. Germany Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 39. France Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 40. France Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 41. France Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 42. France Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 43. France Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 44. Italy Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 45. Italy Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 46. Italy Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 47. Italy Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 48. Italy Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 49. United Kingdom Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 50. United Kingdom Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 51. United Kingdom Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 52. United Kingdom Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 53. United Kingdom Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 54. Russia Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 55. Russia Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 56. Russia Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 57. Russia Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 58. Russia Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 59. Netherlands Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 60. Netherlands Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 61. Netherlands Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 62. Netherlands Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 63. Netherlands Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 64. Spain Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Spain Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 66. Spain Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 67. Spain Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 68. Spain Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 69. Turkey Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 70. Turkey Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 71. Turkey Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 72. Turkey Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 73. Turkey Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 74. Poland Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 75. Poland Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 76. Poland Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 77. Poland Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 78. Poland Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 79. South America Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 80. South America Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 81. South America Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 82. South America Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 83. South America Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 84. South America Synthetic Biology Market Share (%), By Country, 2017-2031F
  • Figure 85. Brazil Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 86. Brazil Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 87. Brazil Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 88. Brazil Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 89. Brazil Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 90. Argentina Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 91. Argentina Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 92. Argentina Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 93. Argentina Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 94. Argentina Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 95. Asia-Pacific Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 96. Asia-Pacific Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 97. Asia-Pacific Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 98. Asia-Pacific Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 99. Asia-Pacific Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 100. Asia-Pacific Synthetic Biology Market Share (%), By Country, 2017-2031F
  • Figure 101. India Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. India Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 103. India Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 104. India Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 105. India Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 106. China Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 107. China Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 108. China Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 109. China Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 110. China Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 111. Japan Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 112. Japan Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 113. Japan Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 114. Japan Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 115. Japan Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 116. Australia Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 117. Australia Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 118. Australia Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 119. Australia Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 120. Australia Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 121. Vietnam Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 122. Vietnam Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 123. Vietnam Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 124. Vietnam Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 125. Vietnam Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 126. South Korea Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. South Korea Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 128. South Korea Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 129. South Korea Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 130. South Korea Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 131. Indonesia Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 132. Indonesia Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 133. Indonesia Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 134. Indonesia Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 135. Indonesia Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 136. Philippines Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 137. Philippines Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 138. Philippines Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 139. Philippines Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 140. Philippines Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 141. Middle East & Africa Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 142. Middle East & Africa Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 143. Middle East & Africa Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 144. Middle East & Africa Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 145. Middle East & Africa Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 146. Middle East & Africa Synthetic Biology Market Share (%), By Country, 2017-2031F
  • Figure 147. Saudi Arabia Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 148. Saudi Arabia Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 149. Saudi Arabia Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 150. Saudi Arabia Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 151. Saudi Arabia Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 152. UAE Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 153. UAE Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 154. UAE Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 155. UAE Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 156. UAE Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 157. South Africa Synthetic Biology Market, By Value, In USD Billion, 2017-2031F
  • Figure 158. South Africa Synthetic Biology Market Share (%), By Tools, 2017-2031F
  • Figure 159. South Africa Synthetic Biology Market Share (%), By Technology, 2017-2031F
  • Figure 160. South Africa Synthetic Biology Market Share (%), By Application, 2017-2031F
  • Figure 161. South Africa Synthetic Biology Market Share (%), By End-user, 2017-2031F
  • Figure 162. By Tools Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023